arBtrage CAPITALIZING MARKETS checking… Sign in

Apogee Therapeutics, Inc.

APGE Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$86.92
▼ -4.4% Today
as of Jun 7, 07:09 ET
Last 30 days +1.82% Apr 28 → Jun 05
$76.70 $80.51 $84.33 $88.14 $91.95 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$90.00
High
$91.90
Low
$85.77
Volume
$1M
Avg Vol
$884,888
Mkt Cap
$5.9B
P/E (TTM)
Beta
52w High
$95.31
52w Low
$34.34
Div Yield
Shares Out
$75M

Overview

52-week range
$34
$95
86% of range
Avg surprise (last 2)
+12.8%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
70%
EM ±9.6% · $85 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.78$-2.96$-2.15$-1.33$-0.51 Actual $-3.78Actual $-0.51Actual $-0.64Actual $-0.60Actual $-0.86Actual $-0.95Est $-1.19Actual $-1.13Actual $-1.11Actual $-1.06Est $-1.12 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-74M$-64M$-55M$-45M$-36M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-1.06 $-1.12 +5.4% -11.6% +1.9% earnings
Tue Sep 30, 2025Sep 2025 $-1.11 financials
Mon Jun 30, 2025Jun 2025 $-1.13 financials
Mon May 12, 2025Mar/2025 $-0.95 $-1.19 +20.2% +6.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.86 financials
Sun Jun 30, 2024Jun 2024 $-0.60 financials
Sun Mar 31, 2024Mar 2024 $-0.64 financials
Sat Sep 30, 2023Sep 2023 $-0.51 financials
Fri Jun 30, 2023Jun 2023 $-3.78 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-83M$-71M$-73M$-63M$-59M$-44M
Net income$-74M$-65M$-66M$-55M$-49M$-34M
EPS (diluted)$-1.06$-1.11$-1.13$-0.95$-0.86$-0.60

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$452M$108M$124M$107M$119M$307M
Inventory
Total current assets$1.07B$741M$540M$516M$522M$530M$534M$682M
Total assets$1.29B$937M$626M$658M$714M$754M$776M$801M
Long-term debt
Total liabilities$38M$33M$40M$38M$41M$37M$42M$27M
Total equity

Implied volatility — last 90 days

64%67%69%72%74% Jun 07 — IV 70% · EM ±9.6%

Sector peers